# OnCo record immunogen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/immunogen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "immunogen" ;
  schema:name "ImmunoGen"@en ;
  schema:alternateName "ImmunoGen, Inc."@en, "NASDAQ:IMGN"@en ;
  schema:description "ImmunoGen made antibody-drug conjugates, antibodies that carry a strong drug to cancer cells. Its medicine Elahere treats ovarian cancer that has stopped responding to platinum chemotherapy. AbbVie bought the company in 2024."@en ;
  schema:url <https://onco.cc/companies/immunogen/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/855654/000110465923122415/tm2331816d2_ex99-1.htm>, <https://www.sec.gov/Archives/edgar/data/855654/000110465924013712/tm245856d1_8k.htm> ;
  schema:addressCountry "US" ;
  onco:related <https://onco.cc/companies/immunome/> ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/folr1/>, <https://onco.cc/targets/cd123/> ;
  onco:drugs <https://onco.cc/drugs/mirvetuximab-soravtansine/>, <https://onco.cc/drugs/pivekimab-sunirine/> .